Related Experiment Video

Updated: Apr 30, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.0K

Causes of hemolysis in neonates with extreme hyperbilirubinemia

R D Christensen1, R H Nussenzveig2, H M Yaish3

  • 1Women and Newborn's Clinical Program, Intermountain Healthcare, Salt Lake City, UT, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|April 26, 2014
PubMed

Insights

Investigating extreme neonatal hyperbilirubinemia revealed genetic causes for jaundice in all evaluated infants. This quality improvement process successfully identified conditions like hereditary spherocytosis and G6PD deficiency.

Area of Science:

  • Neonatal Medicine
  • Clinical Genetics
  • Pediatric Hematology

Background:

  • Extreme hyperbilirubinemia in neonates poses diagnostic challenges.
  • Identifying the underlying cause of jaundice is crucial for appropriate management and preventing complications.

Purpose of the Study:

  • To implement a quality improvement process for diagnosing genetic hemolytic conditions in neonates with extreme hyperbilirubinemia.
  • To enhance the diagnostic yield for rare genetic causes of severe jaundice in newborns.

Main Methods:

  • Implemented a specialized evaluation protocol for neonates with total serum bilirubin (TSB) >25 mg/dL.
  • Utilized erythrocyte membrane antigen (EMA)-flow cytometry for suspected membrane defects and next-generation sequencing for other genetic causes.
  • Included cases with prolonged phototherapy requirements and early high TSB levels.

Main Results:

  • Diagnoses were established in all 12 evaluated neonates.
  • Identified hereditary spherocytosis (n=5), pyruvate kinase deficiency (n=2), severe G6PD deficiency (n=1), and ABO hemolytic disease (n=4).
  • Five neonates had hereditary spherocytosis, with three also having ABO hemolytic disease.

Conclusions:

  • A systematic approach to diagnosing genetic causes of hemolytic disease in neonates with extreme hyperbilirubinemia is effective.
  • Pursuing genetic etiologies can be productive in managing complex neonatal jaundice cases.
  • This quality improvement initiative improved diagnostic capabilities for neonatal hemolytic conditions.
Abstract

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

10.5K

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
35
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.3K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
208
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967